Cargando…

Mutational Characterization of Cutaneous Melanoma Supports Divergent Pathways Model for Melanoma Development

SIMPLE SUMMARY: The divergent pathway model established at least two approaches for melanoma development. One was related to a propensity to melanocytic proliferation (nevogenic), and the other was associated with an accumulation of solar damage (CSD). We conducted a retrospective study to examine w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Millán-Esteban, David, Peña-Chilet, María, García-Casado, Zaida, Manrique-Silva, Esperanza, Requena, Celia, Bañuls, José, López-Guerrero, Jose Antonio, Rodríguez-Hernández, Aranzazu, Traves, Víctor, Dopazo, Joaquín, Virós, Amaya, Kumar, Rajiv, Nagore, Eduardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533762/ https://www.ncbi.nlm.nih.gov/pubmed/34680367 http://dx.doi.org/10.3390/cancers13205219

Ejemplares similares

Distribution and clinical role of KIT gene mutations in melanoma according to subtype. A study on 492 Spanish patients
por: Millán-Esteban, David, et al.
Publicado: (2021)

Cutaneous melanoma primary site is linked to nevus density
por: Martin-Gorgojo, Alejandro, et al.
Publicado: (2017)

Correction: Cutaneous melanoma primary site is linked to nevus density
por: Martin-Gorgojo, Alejandro, et al.
Publicado: (2018)

Prognostic Role of Non-Identification of Sentinel Lymph Node in Cutaneous Melanoma Patients: An Observational Retrospective Study
por: Moro, Ruggero, et al.
Publicado: (2020)

Locoregional Lymph Node Recurrence of Trunk Melanoma in Non-sentinel Lymph Node Basins: An Observational Retrospective Study
por: MORO, Ruggero, et al.
Publicado: (2020)

Telomere length and survival in primary cutaneous melanoma patients
por: Rachakonda, Sivaramakrishna, et al.
Publicado: (2018)

Author Correction: Telomere length and survival in primary cutaneous melanoma patients
por: Rachakonda, Sivaramakrishna, et al.
Publicado: (2018)

Variants at the 9p21 locus and melanoma risk
por: Maccioni, Livia, et al.
Publicado: (2013)

Ultraviolet light-induced collagen degradation inhibits melanoma invasion
por: Budden, Timothy, et al.
Publicado: (2021)

Topographical and Chronological Analysis of Thin Cutaneous Melanoma’s Progressions: A Multicentric Study
por: Chousakos, Emmanouil, et al.
Publicado: (2023)

TERT promoter mutations in melanoma survival
por: Nagore, Eduardo, et al.
Publicado: (2019)

High nevus counts confer a favorable prognosis in melanoma patients
por: Ribero, Simone, et al.
Publicado: (2015)

Exploring the druggable space around the Fanconi anemia pathway using machine learning and mechanistic models
por: Esteban-Medina, Marina, et al.
Publicado: (2019)

3D Bioprinting: An Enabling Technology to Understand Melanoma
por: Fernandes, Samantha, et al.
Publicado: (2022)

Influence of Genetic Variants in Type I Interferon Genes on Melanoma Survival and Therapy
por: Lenci, Romina Elizabeth, et al.
Publicado: (2012)

TERT Promoter Mutations are Associated with Visceral Spreading in Melanoma of the Trunk
por: Osella-Abate, Simona, et al.
Publicado: (2019)

Frequent DPH3 promoter mutations in skin cancers
por: Denisova, Evgeniya, et al.
Publicado: (2015)

Improving Melanoma Classification by Integrating Genetic and Morphologic Features
por: Viros, Amaya, et al.
Publicado: (2008)

rs12512631 on the Group Specific Complement (Vitamin D-Binding Protein GC) Implicated in Melanoma Susceptibility
por: Peña-Chilet, Maria, et al.
Publicado: (2013)

Functional Profiling of Soft Tissue Sarcoma Using Mechanistic Models
por: Payá-Milans, Miriam, et al.
Publicado: (2023)

Crosstalk between Metabolite Production and Signaling Activity in Breast Cancer
por: Çubuk, Cankut, et al.
Publicado: (2023)

Characterization of individuals at high risk of developing melanoma in Latin America: bases for genetic counseling in melanoma
por: Puig, Susana, et al.
Publicado: (2016)

Drug repurposing for COVID-19 using machine learning and mechanistic models of signal transduction circuits related to SARS-CoV-2 infection
por: Loucera, Carlos, et al.
Publicado: (2020)

Capturing the biological impact of CDKN2A and MC1R genes as an early predisposing event in melanoma and non melanoma skin cancer
por: Puig-Butille, Joan Anton, et al.
Publicado: (2013)

Mechanistic Models of Signaling Pathways Reveal the Drug Action Mechanisms behind Gender-Specific Gene Expression for Cancer Treatments
por: Çubuk, Cankut, et al.
Publicado: (2020)

Towards a metagenomics machine learning interpretable model for understanding the transition from adenoma to colorectal cancer
por: Casimiro-Soriguer, Carlos S., et al.
Publicado: (2022)

Discovering potential interactions between rare diseases and COVID-19 by combining mechanistic models of viral infection with statistical modeling
por: López-Sánchez, Macarena, et al.
Publicado: (2022)

Involvement of ANXA5 and ILKAP in Susceptibility to Malignant Melanoma
por: Arroyo-Berdugo, Yoana, et al.
Publicado: (2014)

Editorial: Molecular Genetics of Cutaneous Melanoma: Current Status and Future Direction
por: Pellegrini, Cristina, et al.
Publicado: (2021)

Using mechanistic models for the clinical interpretation of complex genomic variation
por: Peña-Chilet, María, et al.
Publicado: (2019)

Resistance to BRAF inhibitors induces glutamine dependency in melanoma cells
por: Baenke, Franziska, et al.
Publicado: (2015)

Editorial: Molecular genetics of cutaneous melanoma: current status and future direction-volume II
por: Garcia-Casado, Zaida, et al.
Publicado: (2023)

Mechanistic models of signaling pathways deconvolute the glioblastoma single-cell functional landscape
por: Falco, Matías M, et al.
Publicado: (2020)

Real-world evidence with a retrospective cohort of 15,968 COVID-19 hospitalized patients suggests 21 new effective treatments
por: Loucera, Carlos, et al.
Publicado: (2023)

ETS1, nucleolar and non-nucleolar TERT expression in nevus to melanoma progression
por: Kohli, Jaskaren S., et al.
Publicado: (2017)

Protocolo de diagnóstico histológico para muestras de pacientes con melanoma cutáneo. Documento de consenso de la SEAP y la AEDV para el Registro Nacional de Melanoma()
por: Tejera-Vaquerizo, A., et al.
Publicado: (2021)

Informing patients about their mutation tests: CDKN2A c.256G>A in melanoma as an example
por: Hemminki, Kari, et al.
Publicado: (2020)

Brain microenvironment-driven resistance to immune and targeted therapies in acral melanoma
por: Lee, Rebecca Jane, et al.
Publicado: (2020)

A Case Presentation of Three Polypoid Melanomas With Divergent Features
por: Maury, Mikalah E, et al.
Publicado: (2023)

Mapping of deletion breakpoints at the CDKN2A locus in melanoma: detection of MTAP-ANRIL fusion transcripts
por: Xie, Huaping, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_onjbdpjn2jmbu5jsr29cer68ki